同伴递送思考健康计划治疗围产期抑郁:印度个体随机对照试验
在印度果阿邦开展的単盲个体随机对照试验纳入280名围产期抑郁孕妇,比较同伴递送思考健康计划(THPP)联合增强常规照护(EUC)与单独EUC的疗效。THPP对围产期抑郁缓解有中等效应且成本节约。
要点
- 两组严重不良事件无显著差异,THPP成本较低且通过减少医疗、时间和生产力成本实现节约。
核心结论
- 同伴递送的思考健康计划(THPP)对围产期抑郁产后6个月缓解有中等效应,且相对廉价、具有成本节约性。
研究设计与样本
- 单盲、个体随机对照试验在印度果阿邦产前门诊招募18岁及以上、PHQ-9评分至少10分的孕妇。
- 参与者按1:1随机分配至增强常规照护(EUC)组或THPP联合EUC组,随机区组大小随机并按居住地(城市或农村)分层。
- 共纳入280名围产期抑郁女性,THPP联合EUC组140人,单独EUC组140人;主要结局为产后6个月抑郁症状严重程度(PHQ-9评分)和缓解率(PHQ-9评分小于5)。
- 分析按意向性治疗进行,调整预先定义或基线不平衡的协变量;试验注册号NCT02104232。
主要发现
- 产后6个月,THPP联合EUC组122人(87%)和单独EUC组129人(92%)被评估主要结局。
- 两组严重不良事件无显著差异证据。
关键数值与推荐
- 抑郁筛查阳性定义为PHQ-9评分至少10分。
- 缓解定义为PHQ-9评分小于5分。
临床怎么用
- 在社区精神卫生资源有限地区,可考虑由同伴递送思考健康计划以改善围产期抑郁缓解。
- THPP可作为增强常规照护的附加干预,且具有成本节约潜力。
- 需注意THPP对抑郁症状严重程度的改善未达统计学显著,临床决策应结合缓解率与功能改善综合评估。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Thinking Healthy Programme (THP) is a psychological intervention recommended for the treatment of perinatal depression. However, efforts to integrate the intervention at scale into the routines of community health workers who delivered the THP when it was first evaluated were compromised by the competing responsibilities of community health workers. We aimed to assess the effectiveness and cost-effectiveness of THP peer-delivered (THPP) in Goa, India. METHODS: In this single-blind, individually randomised controlled trial, we recruited pregnant women aged 18 years or older who scored at least 10 on the Patient Health Questionnaire-9 (PHQ-9) from antenatal clinics in Goa. Participants were randomly allocated (1:1) to receive enhanced usual care (EUC; so-called because, in India, perinatal depression is not typically treated) only (control group) or THPP in addition to EUC (intervention group) in randomly sized blocks that were stratified by area of residence (urban or rural). Group allocations were concealed from participants and researchers before assignments were made by use of sequentially numbered opaque envelopes. The primary outcomes were the severity of depressive symptoms (assessed by PHQ-9 score) and the prevalence of remission (defined as a PHQ-9 score of less than 5) in participants with available data 6 months after childbirth, which was assessed by researchers who were masked to treatment allocations. We analysed outcomes by intention to treat, adjusting for covariates that were defined a priori or that showed imbalance at baseline. The trial is registered with ClinicalTrials.gov, number NCT02104232. FINDINGS: Between Oct 24, 2014, and June 24, 2016, we assessed 118 260 women for their eligibility for screening, of whom 111 851 (94·6%) women were ineligible. 6409 (5·4%) women were eligible for screening and 6369 (99·4%) of these women consented to be screened with the PHQ-9 (40 women did not consent), of whom 333 (5·2%) screened positive for depression (defined as a PHQ-9 score of at least 10). We enrolled 280 (84·1%) women with perinatal depression; 140 women were assigned to the THPP and EUC group and 140 women to the EUC only group. The final treatment was given on May 27, 2017. The final 6-month outcome assessment was completed on June 9, 2017. At 6 months after birth, 122 (87%) women in the THPP and EUC group and 129 (92%) women in the EUC only group were assessed for the primary outcome. There was a higher prevalence of remission at 6 months after birth in the THPP and EUC group compared with the EUC only group (89 [73%] women in the intervention group vs 77 [60%] women in the control group; prevalence ratio 1·21, 95% CI 1·01 to 1·45; p=0·04), but there was no evidence of a difference in symptom severity between the groups (mean PHQ-9 score 3·47 [SD 4·49] in the intervention group vs 4·48 [5·11] in the control group; standardised mean difference -0·18, 95% CI -0·43 to 0·07; p=0·16). There was no evidence of significant differences in serious adverse events between the groups. INTERPRETATION: THPP had a moderate effect on remission from perinatal depression over the 6-month postnatal period. THPP is relatively cheap to deliver and is cost-saving through reduced health-care, time and productivity costs. FUNDING: National Institute of Mental Health (USA).
引用
- Fuhr DC, Weobong B, Lazarus A, et al. Delivering the Thinking Healthy Programme for perinatal depression through peers: an individually randomised controlled trial in India. Lancet Psychiatry. 2019. PMID: 30686385. doi:10.1016/S2215-0366(18)30466-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。